NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
- Written by PR Newswire Asia - News Pronto RSS
 |
- QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ
- QINLOCK now being considered by PHARMAC for reimbursement
- Data from the INVICTUS Phase 3 study shows QINLOCK reduces risk of disease progression or death by 85%1, 2
SINGAPORE and AUCKLAND, New Zealand, Jan. 20, 2023 /PRNewswire/ -- Independent biopharmaceutical company...